Abstract Objective: To assess the effectiveness and safety of electroacupuncture for the treatment of diabetic peripheral neuropathy (DPN). Clinical studies in China have shown the beneficial effect of electroacupuncture compared with conventional medicine. However, the effectiveness of electroacupuncture has not been well acknowledged internationally. Methods: We searched the following databases from their inception through February 2016: MEDLINE, the Cochrane Central Register of Controlled Trials (April, 2015), SinoMed, China National Knowledge Infrastructure, VIP, Wanfang Database, Chinese Important Conference Papers Database, and the Chinese Dissertation Database. Randomized controlled trials (RCTs) were included if they compared electroacupuncture to conventional medicine, placebo, or no treatment on DPN patients. RevMan 5.3 software was used for data analysis, with effect estimate presented as relative risk (RR) and mean difference (MD) with a 95% confidence interval (CI). Results: Eleven RCTs involving 837 participants were included. The methodological quality of included RCTs was generally poor in terms of sequence generation, allocation concealment, blinding, incomplete outcome data, and selective outcome reporting. Meta-analysis showed that electroacupuncture had a better effect on global symptom improvement than methylcobalamin (RR Z 1.29; 95% CI: 1.14e1.46) and vitamin B (RR Z 1.60; 95% CI: 1.33e1.94). Only two RCTs reported adverse events.
Introduction
Diabetes mellitus is the seventh leading cause of death worldwide, causing 1.4 million deaths in 2011 (about 2.6% of total global deaths for that year). 1 Diabetic peripheral neuropathy (DPN) is one of the most common chronic complications of diabetes mellitus, and is among the main causes of disability. 2 Studies in America have shown that 32.7% of people with diabetes mellitus 3 have evidence of DPN and multicenter studies in Europe have shown that 28% of people with diabetes mellitus have evidence of DPN. 4 The incidence of DPN in worldwide diabetic patients ranges from 5% to 80%, and is still increasing. 5 DPN involves sensory, motor, and autonomic nerve lesions, with sensory neuropathy most frequently experienced. 6 The principle clinical features of DPN are progressive loss of sensation and movement in the distal limbs, manifesting as intense limb numbness, severe pain, muscle weakness and atrophy, and weakening or complete loss of tendon reflexes, ultimately leading to foot ulcers, gangrene, and even amputation. 7, 8 These symptoms result in a huge disease burden in terms of disability and depletion of health care resources. 9e11 The etiology and pathogenesis of DPN have not been fully elucidated. For this reason, ideal drugs have still not been developed. 12 Glycemic control is fundamental in the prevention and treatment of DPN. Medical therapies that are part of the DPN drug arsenal include methylcobalamin (vitamin B 12 ) l to repair nerves, thioctic acid (alpha-lipoic acid) for oxidative stress, prostaglandin E2 to improve microcirculation, aldose reductase inhibitors, such as epalrestat to attenuate morphologic abnormality of the nerves. For symptomatic treatment with anticonvulsants, antidepressants and acesodyne are also used for DPN. 13e16 Existing pharmaceutical drugs usually have side effects and are costly. Thus, the overall financial burden of DPN and its complications has been estimated at more than four billion USD in one year in America alone. 17 Therefore, better therapy options for DPN are needed.
DPN has been treated using acupuncture for 2000 years. 18 There are many types of acupuncture used in China, including auricular, manual, scalp, electroacupuncture, needle tapping, acupoint injection, blood pricking, warm needling, and moxibustion. Electroacupuncture is one of the most widely applied therapies for DPN to ameliorate symptoms, improve quality of life (QoL), and prevent other complications. In recent years, many clinical trials and animal experiments have shown the benefit of electroacupuncture in the treatment of DPN. 19e26 Electroacupuncture for DPN is based on the theory of traditional Chinese medicine (TCM), in which DPN is due to decreases in the body of the fundamental substances of yin and essence, which lead to endogenous dryness that eventually damages the qi and yin. Because of the interdependence of yin and yang, impairment of yin affects yang, and results in deficiency of both yin and yang. 27 Deficiency of yin and the resulting dry-heat will dry the body fluids, allowing pathogenic qi to enter the channels. These two conditions can lead to the stasis of blood and stagnation in the channels such that yang qi cannot reach the ends of the four limbs. The sinews and vessels lack the nourishment provided by qi and blood, which eventually results in DPN.
28e30 As DPN is caused by qi and yin deficiency, blood stasis, and stagnation, the treatment principle involves replenishing qi and nourishing yin, dissolving stasis and unblocking the channels.
This systematic review aimed to evaluate the potential beneficial and harmful effects of electroacupuncture for the treatment of DPN. Information from this review may provide the foundation for formulating guidelines on electroacupuncture for DPN therapy and prevention.
Materials and methods

Data sources and searches
The following electronic databases were searched from their inception through February 2016: MEDLINE (Table 1) English search terms included: "acupuncture," "acupuncture therapy," "needling," "electroacupuncture," "diabetic neuropathy," "diabetic peripheral neuropathy," "DPN," "clinical trial," and "randomized controlled trial." The Chinese search terms were "zhen ci," "zhen jiu," "dian zhen," "tang niao bing shen jing bing bian," "tang niao bing zhou wei shen jing bing bian," "lin chuang shi yan," and "sui ji." The search terms were used individually or in combination. Reference lists of all relevant studies were also hand-searched.
Two authors (WJX, XF) independently conducted the literature search, study selection and data extraction. Disagreement was resolved by discussion, and consensus was reached through discussion with a third party (WC).
Inclusion and exclusion criteria
Parallel randomized controlled trials (RCTs) were included if they involved electroacupuncture for DPN, regardless of publication status.
The definition of DPN must have met the following diagnostic criteria: met international diabetes mellitus and DPN criteria, such as the WHO criteria 31 or the American Diabetes Association (ADA) 32 ; participants had predominantly distal symmetrical sensorimotor polyneuropathy of the limbs. Other causes of multiple sensorimotor neuropathy were excluded.
Our operational definition of electroacupuncture was puncturing the body with acupuncture needles at specific points on the corresponding channel based on TCM syndrome pattern differentiation and treatment, followed by application of electric current through the needles. 33, 34 The control intervention included conventional treatment, sham acupuncture, placebo, or no treatment. RCTs evaluating acupuncture therapy combined with other interventions compared with those other interventions alone were also included.
Primary outcome was global symptom improvement measured by corroborative methods, such as the visual analog scale or by other criteria defined by the investigators. Secondary outcomes included changes in nerve conduction velocity measured by a corroborant instrumentation, QoL, health economics, and adverse events.
Quality assessment
Two authors (WJX, XF) independently assessed the quality of included RCTs according to the Cochrane risk of bias tool. 35 The following types of bias were assessed: random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias), and baseline imbalance (other bias). Disagreement was resolved by discussion, and consensus was reached through discussion with a third party (WC).
Data analysis
RevMan 5.3 software was used to conduct the data analysis. Data were presented as relative risk (RR) with 95% confidence intervals (CI) for dichotomous outcomes, and mean difference (MD) with 95% CI for continuous outcomes. Metaanalysis was planned if the included RCTs had acceptable homogeneity regarding study design, participants, interventions, controls, and outcome measures. We tested heterogeneity using the I 2 statistic with significance set at !50%, and the chi-square statistic significance set at P < 0.10. If we identified significant heterogeneity, the random-effects model would be used. If we identified enough RCTs, we planned to assess possible sources of heterogeneity by subgroup and sensitivity analyses, and to assess the effect of small sample RCTs on results and publication bias using funnel plots.
Results
Description of included studies
A total of 1306 articles were identified through primary retrieval ( Fig. 1) . After reading the titles and abstracts, 1143 articles were excluded because of duplication or inconformity of titles or abstracts. This resulted in 163 articles for further assessment. Of these, 151 articles were excluded because they did not meet our inclusion criteria: inconformity of study type, participants, intervention, control, or outcomes; lack of diagnostic criteria; and duplicate studies. Ultimately, 12 RCTs were included, 36e47 one of which was a three-armed trial. 44 We determined that the studies Li 37 and Li 38 reported different parts of the same RCT, so we combined their data into 1 trial that we referred to as Li YF 2003 . Thus, 11 trials from 12 publications were included in our final analyses.
Characteristics of included RCTs are presented in Table 2 , and treatments performed are presented in 12 , and methylcobalamin), inositol, and thioctic acid (alpha-lipoic acid) injection. No trial used sham acupuncture, placebo, pharmaceutical drugs or no treatment as a control. Hypoglycemic therapy, including oral hypoglycemic agents, insulin, diabetes education, and exercise, was used as a basic therapy in all except one trial. 47 All included trials except one 46 reported global symptom improvement and 8 trials 37e41,43e45,47 reported changes in the motor/sensory nerve conduction velocity. However, for global symptom improvement, the classification and demarcation points of the hierarchical outcomes of the improvement were quite different. For the convenience of analyzing them as dichotomous data, we merged the "cure," "markedly effective," and "effective" outcomes into a single positive category, and merged "ineffective" outcomes into a negative category. Measurements of changes in nerve conduction velocity were also quite different. Only 2 trials 42, 46 reported adverse events, and no trial evaluated QoL or health economics. 
Quality assessment
Although all included trials mentioned "random allocation," only 5 trials 37e39,44e46 described the method of random sequence generation such as using a random number table (Figs. 2 and 3) . No trial mentioned allocation concealment or blinding. For incomplete outcome data, no trial provided information on drop-outs such as number of missing cases and the reason for the deletion. No trial reported intention-to-treat (ITT) analysis. With regard to selective reporting, we classified all included trials as unclear risk of bias because the study protocols were unattainable. No trial reported sample calculation, and 1 RCT 42 did not report whether the baseline characteristics of the treatment and the control group were comparable.
Effect estimates
The effect estimates of electroacupuncture are shown in Table 4 .
Effect on global symptom improvement
Ten trials 36e45,47 reported global symptom improvement outcomes (Fig. 4) . Results showed that electroacupuncture had a better curative effect than methylcobalamin (RR 1.29; 95% CI 1.14 to 1.46) and vitamin B (RR 1.60; 95% CI 1.33 to 1.94). Electroacupuncture plus methylcobalamin versus methylcobalamin alone (RR Z 1.20; 95% CI: 1.03e1.40) and electroacupuncture plus thioctic acid injection versus thioctic acid injection alone (RR Z 1.23; 95% CI: 1.02e1.47) also showed a better curative effect on global symptom improvement. Subgroup and sensitivity Vitamins B 1 (100 mg/mL) and B 12 (500 mg/mL), both IM and QD, 30 days as 1 course, total of 1 course.
Abbreviations: BID, 2 times daily; EA, electroacupuncture; QD, once daily; TID, 3 times daily. Fig. 2 Risk of bias graph.
analyses were not performed because of the low heterogeneity (I 2 Z 33%).
Effect on changes in nerve conduction velocity Eight trials 37e41,43e45,47 reported the outcomes of changes in nerve conduction velocity. A total of 21 kinds of nerve conduction velocity tests of 6 different nerves were measured. Six trials 39e41, 43, 45, 47 indicated that electroacupuncture had a beneficial effect on nerve conduction velocity, while 2 trials 37,38,44 did not. The combined trial of Li 37, 38 found that methylcobalamin had a better therapeutic effect than electroacupuncture on motor nerve conduction velocity in the left median and tibial nerves, and on motor nerve conduction velocity in the right median, tibial and ulnar nerves. Another trial 44 found that thioctic acid injection had a better effect than electroacupuncture on changes in motor nerve conduction velocity in the left ulnar nerve, and on sensory nerve conduction velocity in the left median nerve.
Adverse events
In the 2 trials 42,46 that reported adverse events, no serious untoward events occurred. The remaining trials did not report adverse events.
Funnel plot analysis
Based on guidelines delineated in the Cochrane Handbook of Systematic Reviews of Interventions, 35 funnel plot analysis was not conducted due to the small number of included RCTs and the diversity of comparisons and outcomes.
Discussion
This review could not obtain conclusive evidence about the therapeutic effect of electroacupuncture for DPN because of the poor methodological quality of the included trials. There was no strong evidence to recommend electroacupuncture for DPN, and the positive findings should be interpreted conservatively.
The review showed that limitations existed in both study design and the implementation process of included RCTs. The methodological quality of the included trials was generally poor, which increased risk of bias of the evaluation for interventions. All included trials mentioned random allocation, however, only 5 trials 37e39,44e46 provided information regarding the method of randomization, and this was insufficient to judge whether the randomization was performed adequately. None of the trials adopted allocation concealment, which might have led to the investigators having prior knowledge of the allocation sequence, and caused selection bias. Blinding method was not reported in any included trials. Both the investigator and the participants clearly knew which treatment was being given, which may have introduced bias due to the confounding factor of the placebo effect. We concede that for trials of different forms of intervention and control groups, the application of blinding to researchers and subjects would have been difficult, however, blinding could still have been used on outcome assessors. Blinding of the outcome assessors would have been especially important for assessing the subjective outcome of the patients' selfreported index. No trial provided specific information regarding drop-outs and follow-up, and ITT analysis was not performed to ensure authenticity of the results. The preregistered protocols of the included trials could not be accessed, which prohibited us from judging whether there was publication bias. No included trial reported that sample calculation had been performed, such that this and the absence of pre-registered protocols may have led to other bias. One trial 42 did not report whether the baseline characteristics of the treatment and control group were comparable, so we deemed the risk of other bias in this RCT to be high. Several problems existed in the study design of included RCTs. Reporting of the baseline characteristics of participants was not standardized, the inclusion and exclusion criteria were indeterminate, the age range of participants was large, and the TCM syndrome pattern differentiation was lacking. These factors may have resulted in an imbalance between intervention and control groups such as the imbalance of the types of syndrome patterns that were included, reduced the validity of outcomes, and did not reflect the uniqueness of TCM treatment based on pattern differentiation. Future investigators should standardize study design and the reporting of baseline characteristics, and fully integrate TCM theory with their studies.
With regard to electroacupuncture intervention, there were considerable differences in needling instruments used, number of needling sessions, selection of acupoints, depth of insertion, method of needle manipulation, and needle retention time. None of the included trials mentioned the practitioners' background in accordance with the CONSORT Statement 51 and STRICTA recommendation, 52 such as their qualifications, professional affiliation, or how long they had been practicing acupuncture. Future studies should adopt more rigorous reporting of interventions.
For control treatments, we regrettably found that other control treatments have not been found except vitamin B, inositol or alpha-lipoic acid in included trials. The pharmaceutical drugs which are mainly used for DPN, especially in the U.S would be an important comparison for future RCT studies.
In terms of outcome measurement, the therapeutic effect index of each included trial was quite different, and these were not reported in accordance with the unified international standard such as CONSORT Statement 51 and STRICTA recommendation. 52 The majority of RCTs reported global symptom improvement and changes in nerve conduction velocity. However, the former was reported as a hierarchical outcome using categories, such as "markedly effective", "effective" and "ineffective" and the grading standards of included RCTs were varied and lacked unified international standardization such as CONSORT Statement 51 and STRICTA recommendation. 52 For the convenience of analysis, we summed these as binary outcomes, which probably enlarged the uncertainty of results. Moreover, for the changes in nerve conduction velocity, the nerves measured in each trial were too varied to perform a metaanalysis and draw a pooled result. No trial reported QoL or health economic outcomes, and the reports of follow-up results were insufficient for estimating long-term therapeutic effects of the treatment. Furthermore, of all the included trials, only 2 studies 42, 46 reported adverse events. This is a universal phenomenon of TCM trials performed and published in China, where researchers often consider treatments to be safe and overlook the importance of safety reporting. Because of this, we cannot ascertain the safety of electroacupuncture, and recommend comprehensive monitoring and reporting of adverse events are needed in all future studies.
Our search found 1 published systematic review on manual acupuncture for DPN 53 However, manual acupuncture and electroacupuncture are different types of acupuncture therapy, and their therapeutic mechanisms and curative effects likely differ. For this reason, we did not include that study. Our review had some limitations. We only searched Chinese and English databases and relevant references because of the language barrier. RCTs of electroacupuncture for DPN published in other languages still need to be assessed to more completely evaluate the effectiveness and safety of electroacupuncture.
Conclusion
We were unable to obtain conclusive evidence about the therapeutic effect of electroacupuncture for DPN through this review because the poor methodological quality of the included trials reduced the reliability of our findings. More rigorously designed, multicenter, double-blind RCTs with reliable quality and credible conclusions are needed to substantiate findings. Future RCTs should include information about needling instruments, number of needling sessions, selection of acupoints, depth of insertion, needle manipulation, needle retention time, and the qualification and experience of the practitioner. Long-term follow-up, monitoring and reporting of adverse events are also required.
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